Medical Waste Containers Market

Executive Summary

Medical Waste Containers Market was valued at US $2,200.37 million in 2021 and is projected to grow at 7.00% CAGR over the forecast period to reach US $3,302.41 million by 2027. Medical Waste Containers Market represented US $278.53 million opportunity over 2019-2021 and estimated to create US $1,102.03 million opportunity in 2027 over 2021.

Medical Waste Containers from Consainsights analyses the Medical Waste Containers Market in the Life Sciences industry over the forecast period to 2027.

Medical Waste Containers research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Medical Waste Containers segmentation includes Type of Waste, Product, End-User and Geography.

Based on the Type of Waste, the Medical Waste Containers analysis covers General Medical Waste, Infectious Medical Waste, Hazardous Medical Waste, Others.

In Type of Waste segment, General Medical Waste segment has highest cagr growth of 6.20%.

Based on the Product, the Medical Waste Containers analysis covers Chemotherapy Containers, Biohazardous Medical Waste Containers, Sharps Medical Waste Containers, Resource Conservation and Recovery Act (RCRA) Containers, Others.

In Product segment, Chemotherapy Containers segment has highest cagr growth of 6.20%.

Based on the End-User, the Medical Waste Containers analysis covers Hospitals & Private Clinics, Pharmacetical and Biotechnology Companies & CROs, Academic Research Institutes, Other End Users.

In End-User segment, Hospitals & Private Clinics segment has highest cagr growth of 6.20%.

Based on the region, the Medical Waste Containers analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Becton, Dickinson and Company, Bemis Manufacturing Company, Bondtech Corporation, Daniels Health, Medgen Medical Products, Stericycle, Mauser Group, Cardinal Health Inc., Sharps Compliance, Inc., Thermo Fisher Scientific, Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Type of Waste

Introduction

In 2021, General Medical Waste segment has the highest revenue of US $1,047.92 million and is expected to grow at CAGR of 6.20% by 2027 General Medical Waste segment has highest cagr growth of 6.20%.

General Medical Waste

General Medical Waste segment was valued at US $915.27 million in 2019 and is projected to grow at 6.20% CAGR over the forecast period to reach US $1,572.76 million by 2027. General Medical Waste segment represented US $132.65 million opportunity over 2019-2021 and estimated to create US $524.84 million opportunity in 2027 over 2021.

Infectious Medical Waste

Infectious Medical Waste segment was valued at US $503.17 million in 2019 and is projected to grow at 6.20% CAGR over the forecast period to reach US $864.62 million by 2027. Infectious Medical Waste segment represented US $72.92 million opportunity over 2019-2021 and estimated to create US $288.53 million opportunity in 2027 over 2021.

Hazardous Medical Waste

Hazardous Medical Waste segment was valued at US $334.95 million in 2019 and is projected to grow at 6.20% CAGR over the forecast period to reach US $575.56 million by 2027. Hazardous Medical Waste segment represented US $48.54 million opportunity over 2019-2021 and estimated to create US $192.07 million opportunity in 2027 over 2021.

Others

Others segment was valued at US $168.46 million in 2019 and is projected to grow at 6.20% CAGR over the forecast period to reach US $289.47 million by 2027. Others segment represented US $24.41 million opportunity over 2019-2021 and estimated to create US $96.60 million opportunity in 2027 over 2021.

Product

Introduction

In 2021, Chemotherapy Containers segment has the highest revenue of US $846.33 million and is expected to grow at CAGR of 6.20% by 2027 Chemotherapy Containers segment has highest cagr growth of 6.20%.

Chemotherapy Containers

Chemotherapy Containers segment was valued at US $739.20 million in 2019 and is projected to grow at 6.20% CAGR over the forecast period to reach US $1,270.21 million by 2027. Chemotherapy Containers segment represented US $107.13 million opportunity over 2019-2021 and estimated to create US $423.88 million opportunity in 2027 over 2021.

Biohazardous Medical Waste Containers

Biohazardous Medical Waste Containers segment was valued at US $452.30 million in 2019 and is projected to grow at 6.20% CAGR over the forecast period to reach US $777.22 million by 2027. Biohazardous Medical Waste Containers segment represented US $65.55 million opportunity over 2019-2021 and estimated to create US $259.36 million opportunity in 2027 over 2021.

Sharps Medical Waste Containers

Sharps Medical Waste Containers segment was valued at US $290.42 million in 2019 and is projected to grow at 6.20% CAGR over the forecast period to reach US $499.04 million by 2027. Sharps Medical Waste Containers segment represented US $42.09 million opportunity over 2019-2021 and estimated to create US $166.53 million opportunity in 2027 over 2021.

Resource Conservation and Recovery Act (RCRA) Containers

Resource Conservation and Recovery Act (RCRA) Containers segment was valued at US $244.51 million in 2019 and is projected to grow at 6.20% CAGR over the forecast period to reach US $420.15 million by 2027. Resource Conservation and Recovery Act (RCRA) Containers segment represented US $35.44 million opportunity over 2019-2021 and estimated to create US $140.21 million opportunity in 2027 over 2021.

Others

Others segment was valued at US $195.42 million in 2019 and is projected to grow at 6.20% CAGR over the forecast period to reach US $335.80 million by 2027. Others segment represented US $28.32 million opportunity over 2019-2021 and estimated to create US $112.06 million opportunity in 2027 over 2021.

End-User

Introduction

In 2021, Hospitals & Private Clinics segment has the highest revenue of US $932.75 million and is expected to grow at CAGR of 6.20% by 2027 Hospitals & Private Clinics segment has highest cagr growth of 6.20%.

Hospitals & Private Clinics

Hospitals & Private Clinics segment was valued at US $814.68 million in 2019 and is projected to grow at 6.20% CAGR over the forecast period to reach US $1,399.91 million by 2027. Hospitals & Private Clinics segment represented US $118.07 million opportunity over 2019-2021 and estimated to create US $467.16 million opportunity in 2027 over 2021.

Pharmacetical and Biotechnology Companies & CROs

Pharmacetical and Biotechnology Companies & CROs segment was valued at US $540.05 million in 2019 and is projected to grow at 6.20% CAGR over the forecast period to reach US $928.00 million by 2027. Pharmacetical and Biotechnology Companies & CROs segment represented US $78.27 million opportunity over 2019-2021 and estimated to create US $309.68 million opportunity in 2027 over 2021.

Academic Research Institutes

Academic Research Institutes segment was valued at US $528.71 million in 2019 and is projected to grow at 6.20% CAGR over the forecast period to reach US $908.52 million by 2027. Academic Research Institutes segment represented US $76.63 million opportunity over 2019-2021 and estimated to create US $303.18 million opportunity in 2027 over 2021.

Other End Users

Other End Users segment was valued at US $38.40 million in 2019 and is projected to grow at 6.20% CAGR over the forecast period to reach US $65.98 million by 2027. Other End Users segment represented US $5.56 million opportunity over 2019-2021 and estimated to create US $22.02 million opportunity in 2027 over 2021.